Navigo Proteins GmbH
General information
Navigo Proteins GmbH
Heinrich-Damerow-Straße 1
06120 Halle, Saxony-Anhalt
Germany
Contact person: Henning Afflerbach, Chief Executive Officer
Company main phone: +49 (345) 27996330
Company main fax: +49 (345) 27996332
Website: https://www.navigo-proteins.com
Heinrich-Damerow-Straße 1
06120 Halle, Saxony-Anhalt
Germany
Contact person: Henning Afflerbach, Chief Executive Officer
Company main phone: +49 (345) 27996330
Company main fax: +49 (345) 27996332
Website: https://www.navigo-proteins.com
| Year founded: | 2017 |
| Source of foundation: | Independent foundation |
Corporate description / mission:
Navigo Proteins is a protein engineering company developing optimized affinity ligands, based on the proprietary platform of selected, small, and stable, yet highly engineerable scaffold proteins. These ligands serve as target-binding proteins in biotherapeutic molecules (precision targeting) or for commercial custom affinity purification of biologics (precision capturing®). The company is focused on developing next-generation targeted therapeutics and diagnostics, based on novel, proprietary target binding proteins called Affilin® ligands. Affilin® ligands can mimic the functional binding of antibodies, extending their use to many more applications.
Navigo Proteins is a protein engineering company developing optimized affinity ligands, based on the proprietary platform of selected, small, and stable, yet highly engineerable scaffold proteins. These ligands serve as target-binding proteins in biotherapeutic molecules (precision targeting) or for commercial custom affinity purification of biologics (precision capturing®). The company is focused on developing next-generation targeted therapeutics and diagnostics, based on novel, proprietary target binding proteins called Affilin® ligands. Affilin® ligands can mimic the functional binding of antibodies, extending their use to many more applications.
State of ownership: Private / independent
Headquarters: HQ: Yes
Headquarters: HQ: Yes
Remarks on ownership / listings
Formerly known as Scil Proteins GmbH.
In 2017, Scil Proteins GmbH was acquired by UV-Cap GmbH & Co KG, and the new company was renamed to Navigo Proteins GmbH.
Formerly known as Scil Proteins GmbH.
In 2017, Scil Proteins GmbH was acquired by UV-Cap GmbH & Co KG, and the new company was renamed to Navigo Proteins GmbH.
Categorization
| Sector: |
|
| Subsector: |
|
| Primary therapeutic areas: |
|
| Business model: |
|
| Customer segments: |
|
| Distribution: |
|
Summary Products / Services / Technologies
Number of Biotech Products
| Pre-clinical: | 4 |
Technology used:
Precision Capturing® Technology: non-antibody and antibody purification.
Precision Targeting Technology: protein engineering to create proprietary Affilin® molecules.
Precision Capturing® Technology: non-antibody and antibody purification.
Precision Targeting Technology: protein engineering to create proprietary Affilin® molecules.
© 2024 Biotechgate by Venture Valuation